Drug development in Alzheimer's disease: The path to 2025

Jeffrey Cummings, Paul S. Aisen, Bruno Dubois, Lutz Frölich, Clifford R. Jack, Roy W. Jones, John C. Morris, Joel Raskin, Sherie A. Dowsett, Philip Scheltens

Research output: Contribution to journalArticlepeer-review

185 Scopus citations

Fingerprint

Dive into the research topics of 'Drug development in Alzheimer's disease: The path to 2025'. Together they form a unique fingerprint.

Medicine & Life Sciences